Insider Transactions in Q1 2026 at Arcellx, Inc. (ACLX)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 06
2026
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
13,064
+23.22%
|
-
|
|
Jan 06
2026
|
Rami Elghandour |
BUY
Exercise of conversion of derivative security
|
Direct |
55,991
+6.68%
|
-
|
|
Jan 06
2026
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
20,530
+24.05%
|
-
|
|
Jan 03
2026
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
16,520
+35.41%
|
-
|
|
Jan 03
2026
|
Rami Elghandour |
BUY
Exercise of conversion of derivative security
|
Direct |
53,098
+6.81%
|
-
|
|
Jan 03
2026
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,340
+25.72%
|
-
|
|
Jan 02
2026
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
13,021
+48.89%
|
-
|
|
Jan 02
2026
|
Rami Elghandour |
BUY
Exercise of conversion of derivative security
|
Direct |
55,459
+7.61%
|
-
|
|
Jan 02
2026
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
20,496
+41.44%
|
-
|